Related Experiment Videos
Does tolerance develop to levodopa? Comparison of 2- and 21-H levodopa infusions
J G Nutt1, J H Carter, W Woodward
1Department of Neurology, School of Medicine, Oregon Health Sciences University, Portland 97201.
Summary
Acute tolerance to levodopa may develop with continuous infusion. Longer levodopa infusions resulted in shorter response durations and increased dyskinesia, suggesting tolerance may impact parkinsonism control.
Area of Science:
- Neuroscience
- Pharmacology
- Movement Disorders
Background:
- Levodopa is a primary treatment for Parkinson's disease.
- Patients often experience motor fluctuations and dyskinesia with long-term levodopa use.
- The development of acute tolerance to levodopa is not fully understood.
Purpose of the Study:
- To investigate the development of acute tolerance to levodopa.
- To compare the effects of short-term versus prolonged levodopa infusions.
- To assess the impact of levodopa infusion duration on treatment response and dyskinesia.
Main Methods:
- Comparison of patient responses to 2-hour and 21-hour levodopa infusions.
- Levodopa infusion rates were adjusted to maintain consistent plasma concentrations.
- Evaluation of response duration and dyskinesia severity after infusion cessation.
Main Results:
- The duration of therapeutic response was shorter after 21-hour infusions compared to 2-hour infusions.
- Increased severity of levodopa-induced dyskinesia was observed during the prolonged infusions.
- Findings suggest the development of acute tolerance to levodopa.
Conclusions:
- Continuous dopaminergic stimulation with levodopa may lead to acute tolerance.
- Prolonged levodopa administration might not provide optimal or sustained control of parkinsonism symptoms.
- Alternative strategies may be needed for patients with fluctuating responses to levodopa.